Severe metabolic acidosis secondary to iatrogenic hyperglycaemia in secondary cytoreduction and hyperthermic intraperitoneal chemotherapy (HiPEC).
作者信息
Sogal Sachin, Mishra Priyanka, Govil Nishith
机构信息
Department of Anesthesiology and Critical Care, AIIMS, Rishikesh, Uttarakhand, India.
出版信息
Indian J Anaesth. 2020 Sep;64(9):821-823. doi: 10.4103/ija.IJA_536_20. Epub 2020 Sep 1.
Abstract
摘要
相似文献
1
Severe metabolic acidosis secondary to iatrogenic hyperglycaemia in secondary cytoreduction and hyperthermic intraperitoneal chemotherapy (HiPEC).
Indian J Anaesth. 2020 Sep;64(9):821-823. doi: 10.4103/ija.IJA_536_20. Epub 2020 Sep 1.
2
3
Hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis.
Am J Surg. 2015 Sep;210(3):424-30. doi: 10.1016/j.amjsurg.2015.03.008. Epub 2015 May 12.
4
Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Minerva Chir. 2014 Feb;69(1):27-35.
5
Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study.
JMIR Res Protoc. 2017 Jul 13;6(7):e136. doi: 10.2196/resprot.7790.
6
Cytoreduction surgery with hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer improves progression-free survival, especially in BRCA-positive patients- a case-control study.
J Surg Oncol. 2014 Nov;110(6):661-5. doi: 10.1002/jso.23688. Epub 2014 Jun 24.
7
8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
Ann Surg Oncol. 2008 Sep;15(9):2426-32. doi: 10.1245/s10434-008-9966-2. Epub 2008 Jun 3.
8
Hyperthermic Intraperitoneal Chemotherapy after Secondary Cytoreduction in Epithelial Ovarian Cancer: A Single-center Comparative Analysis.
Ann Surg Oncol. 2016 Apr;23(4):1294-301. doi: 10.1245/s10434-015-4991-4. Epub 2015 Dec 1.
9
Treatment of microscopic disease with hyperthermic intraoperative intraperitoneal chemotherapy after complete cytoreduction improves disease-free survival in patients with stage IIIC/IV ovarian cancer.
Ann Surg Oncol. 2014 Jul;21(7):2383-9. doi: 10.1245/s10434-014-3599-4. Epub 2014 Mar 6.
10
Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for children, adolescents, and young adults: the first 50 cases.
Ann Surg Oncol. 2015 May;22(5):1726-32. doi: 10.1245/s10434-014-4289-y. Epub 2015 Jan 7.
本文引用的文献
1
Society of Onco-Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).
Indian J Anaesth. 2019 Dec;63(12):972-987. doi: 10.4103/ija.IJA_765_19. Epub 2019 Dec 11.
2
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Fluid and temperature remain the culprit!
Indian J Anaesth. 2018 Mar;62(3):162-165. doi: 10.4103/ija.IJA_170_18.
3
Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle.
J Cachexia Sarcopenia Muscle. 2016 Dec;7(5):615-625. doi: 10.1002/jcsm.12104. Epub 2016 Feb 15.
4
Hyperthermic intraperitoneal chemotherapy: Rationale and technique.
World J Gastrointest Oncol. 2010 Feb 15;2(2):68-75. doi: 10.4251/wjgo.v2.i2.68.
Zotero 插件